Full Sponsorship Acquired for UC-MSC Phase III Trial to Repair Severe COVID Lung Damage
Full sponsorship of the phase II trial of UC-MS infusions to treat severe lung damage in COVID-19 ARDS has been successfully transferred to a corporate entity which will soon begin a large randomized double-blind multi-site trial. The initial research for the...
An Announcement From The Cure Alliance Regarding Phase III Of The Clinical Trial For Treatment Of COVID-Related Lung Damage
Full sponsorship of the phase III trial of UC-MSC infusions to treat severe lung damage in COVID-19 ARDS has been successfully transferred to a corporate entity which will soon begin a large randomized double-blind multi-site trial. The initial research for the...
Ricordi’s UC-MSC COVID19 Trial Gets $3M Infusion
FOR IMMEDIATE RELEASE: Miami, Fla. (May 6, 2020) – The Diabetes Research Institute Foundation (DRIF) today announced a donation of $3 million from North America’s Building Trades Unions (NABTU), to support the clinical trial of umbilical cord mesenchymal stem cells...
Planning Begins For Phase II Trial Of UC-MSC For Most Severe COVID-19 Cases
The Cure Alliance announces the start of planning for phase II of the clinical trial of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation IN COVID-19.
New Cell Therapy Trial Launches for Patients with Severe COVID-19
FOR IMMEDIATE RELEASE: APRIL 9, 2020 After a lightning round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of...
Former Morning TV Chief Named President of The Cure Alliance
UCLA’S CHARLES BRUNICARDI , M.D., JOINS THE BOARDGLOBAL SCIENTISTS OFFICIALLY LAUNCH NON-PROFIT (April 8, 2015 Miami, FL.) Former executive producer of ABC’s Good Morning America, Shelley Ross, has been named president of The Cure Alliance it was announced...